Scholar Rock Holding Corporation (SRRK) Earnings Per Share (EPS)
Scholar Rock Holding Corporation (SRRK) diluted earnings per share by fiscal period. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | -$2.81 |
| 2021-12-31 | -$3.59 |
| 2022-12-31 | -$2.26 |
| 2023-12-31 | -$1.99 |
| 2024-12-31 | -$2.47 |
| 2025-12-31 | -$3.29 |
How SRRK compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| DNLI | Denali Therapeutics Inc. | -$2.97 |
| EYPT | EyePoint Pharmaceuticals Inc. | -$3.17 |
| KURA | Kura Oncology Inc. | -$3.18 |
| SNDX | Syndax Pharmaceuticals Inc. | -$3.29 |
| REPL | Replimune Group Inc. | -$3.38 |
These are five companies in the same sector as SRRK with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Scholar Rock Holding Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("SRRK")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SRRK | $52.52 | +0.00% | 0.94M |
| 3 | ||||
| 4 | ||||
| 5 |